Retrospective two-centre study of human tularemia, Austria - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

A Two-Centre Retrospective Analysis of Human Tularemia Cases in Austria

  • By

  • Lorenz Schubert

  • Sarah Stanojevic

  • Carolina Krauss

  • Selma Tobudic

  • Rainer Gattringer

  • Stefan Winkler

  • October 9, 2026

Share

  • 1

    This two-centre retrospective study analyzed 51 patients with tularemia treated in Austria from 2005 through 2024.

  • 2

    Thirty-seven patients (72.5%) received monotherapy, most commonly doxycycline (31 patients; 60.8%).

  • 3

    Fourteen patients (27.5%) received combination therapy, most often doxycycline with an aminoglycoside or a fluoroquinolone.

  • 4

    Among 10 reported monotherapy failures, 5 involved ulceroglandular disease, 3 glandular disease, and 2 pulmonary disease.

  • 5

    Nine treatment failures occurred among 31 patients receiving doxycycline monotherapy (29%); one occurred with fluoroquinolone monotherapy.

Original Source(s)

Retrospective two-centre study of human tularemia, Austria

  • by Lorenz Schubert, Sarah Stanojevic, Carolina Krauss, Selma Tobudic, Rainer Gattringer, Stefan Winkler

  • October 9, 2026

Related Content

FDA expands bladder cancer therapy approval

The expansion offers another treatment option for patients with high-grade tumors following BCG failure.

RE: Putting the PASC Score to the Test: Clinical vs. Statistical Accuracy in Long COVID Diagnosis (Azola et al. JGIM)

Predictors of postdischarge mortality among hospitalised children aged 5−14 years at tertiary hospitals in Tanzania: a prospective observational cohort study